- Home
- ALB vs VRNA Comparison
ALB vs VRNA Comparison
Compare ALB & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALB
- VRNA
- Stock Information
- Founded
- ALB 1994
- VRNA 2005
- Country
- ALB United States
- VRNA United Kingdom
- Employees
- ALB N/A
- VRNA N/A
- Industry
- ALB Major Chemicals
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- ALB Industrials
- VRNA Health Care
- Exchange
- ALB Nasdaq
- VRNA Nasdaq
- Market Cap
- ALB 10.3B
- VRNA 8.3B
- IPO Year
- ALB 1994
- VRNA 2017
- Fundamental
- Price
- ALB $79.30
- VRNA $106.24
- Analyst Decision
- ALB Hold
- VRNA Buy
- Analyst Count
- ALB 16
- VRNA 11
- Target Price
- ALB $86.07
- VRNA $114.10
- AVG Volume (30 Days)
- ALB 4.2M
- VRNA 1.3M
- Earning Date
- ALB 07-30-2025
- VRNA 11-03-2025
- Dividend Yield
- ALB 2.04%
- VRNA N/A
- EPS Growth
- ALB N/A
- VRNA N/A
- EPS
- ALB N/A
- VRNA N/A
- Revenue
- ALB $4,993,278,000.00
- VRNA $221,673,000.00
- Revenue This Year
- ALB N/A
- VRNA $896.59
- Revenue Next Year
- ALB $7.42
- VRNA $77.56
- P/E Ratio
- ALB N/A
- VRNA N/A
- Revenue Growth
- ALB N/A
- VRNA N/A
- 52 Week Low
- ALB $49.43
- VRNA $24.50
- 52 Week High
- ALB $113.91
- VRNA $106.20
- Technical
- Relative Strength Index (RSI)
- ALB 51.05
- VRNA 71.68
- Support Level
- ALB $75.88
- VRNA $105.23
- Resistance Level
- ALB $87.08
- VRNA $105.85
- Average True Range (ATR)
- ALB 3.09
- VRNA 0.28
- MACD
- ALB -0.53
- VRNA -0.24
- Stochastic Oscillator
- ALB 28.29
- VRNA 97.17
About ALB Albemarle Corporation
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.